ArticleNeoplasia (New York, N.Y.)2016

Elucidation of Resistance Mechanisms to Second-Generation ALK Inhibitors Alectinib and Ceritinib in Non-Small Cell Lung Cancer Cells.

Xuyuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.